Easily Own Your Safety Solution and
Gain Control and Visibility

An FDAnews FREE Webinar • Sponsored by Veeva
Thursday, Dec. 5, 2019 • 12:00 p.m. - 1:00 p.m. EST

Apellis Pharmaceuticals shares their experience on quickly moving to a comprehensive and validated cloud safety solution. With one system for case intake, case processing, reporting, submissions, and all document management activities, such as pharmacovigilance safety master file (PSMF) and pharmacovigilance (PV) agreements, pharmacovigilance processes are consolidated, simplified, and streamlined. The safety team can perform many different activities without having to switch between multiple applications: search for duplicates, view any case version, create user-specific line listings and visualizations, seamlessly drill down into the case narrative, see previous edits, revisions and annotations, electronically submit ICSRs and exchange case reports with business partners, and create aggregate report data and written content based on company-specific templates.

Cloud also enables all parties to easily engage on the same platform, promoting greater oversight and alignment. Apellis can provide specific access to partners or internal teams access, supporting collaboration while controlling what users see or do in the application.

Learn how Apellis evaluated a pharmacovigilance system and why they chose a modern solution including:

  • Evaluation criteria as well as benefits and risks of a cloud application
  • How operations are simplified with a unified pharmacovigilance solution
  • Enabling a flexible operating model to easily support change in vendors or responsibilities
  • Vision for how safety will interact with different functional areas across the value chain with a modern platform

Who Will Benefit

  • Biosafety professional
  • Safety manager
  • Risk manager
  • Regulatory specialist
  • Head of PV
  • Head of PV IT
  • Head of Safety Operations
  • Safety Specialists
  • Safety Scientist
  • Aggregate Report Specialist
  • PV Agreements Specialist
  • PSMF Coordinator
  • Medical Reviewers

Sign Up for FREE Below

Meet Your Presenter


Marc Morris, M.D., J.D.

VP, Safety and Pharmacovigilance, Apellis Pharmaceuticals

Marc is responsible for the safety risk management of Apellis products, supporting safe and informed treatment, and fulfilling global regulatory requirements for patient safety. With 18 years in safety risk management, he has extensive experience in safety surveillance and risk mitigation with marketed products and drugs in development at companies such as Roche, GlaxoSmithKline, and BeiGene. Dr. Morris has a special interest in specialty therapies for patients with serious illnesses, including pharmaceuticals and biological products. Dr. Morris has degrees in biochemistry and medicine from the University of London, a masters in pharmaceutical medicine from the University of Surrey, and a law degree from Temple University.